Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
The Core Laboratory in Medical Center of Clinical Research, Department of Endocrinology, Shanghai Ninth People's Hospital, State Key Laboratory of Medical Genomics, Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai 200011, China.
EBioMedicine. 2019 Oct;48:143-160. doi: 10.1016/j.ebiom.2019.08.037. Epub 2019 Oct 4.
Oxidative stress and their effectors play critical roles in carcinogenesis and chemoresistance. However, the role of oxidative stress-related genes variants in biliary tract cancer (BTC) chemoresistance remains unknown. In this work, we aim to investigate oxidative stress-dependent molecular mechanisms underlying chemoresistance, and find potential biomarkers to predict chemotherapy response for BTC.
Sixty-six SNPs in 21 oxidative stress-related genes were genotyped and analyzed in 367 BTC patients. Immunoblot, immunohistochemical, immunofluorescent, quantitative PCR, chromatin immunoprecipitation analysis and study of animal xenograft models were performed to discover oxidative stress-related susceptibility genes underlying chemoresistance mechanism of BTC.
We found that 3 functional polymorphisms (CAT_rs769217, GPX4_rs4807542, and GSR_rs3779647), which were shown to affect their respective gene expression levels, modified the effect of chemotherapy on overall survival (OS). We then demonstrated that knockdown of GPX4, CAT, or GSR induced chemoresistance through elevation of ROS level and activation of Nrf2-ABCG2 pathway in BTC cell lines. Moreover, the association between Nrf2 expression and BTC prognosis is only found in patients who received chemotherapy. Knockdown of Nrf2 enhanced chemosensitivity or even eliminated postoperative recurrence in BTC xenograft mouse models. Importantly, upon chemotherapy treatment patients harboring high oxidative stress-related score received higher survival benefit from adjuvant chemotherapy compared with patients with low oxidative stress-related score.
The result of our study suggests, for the first time, that the oxidative stress-related score calculated by combining variations in CAT, GPX4, and GSR or Nrf2 expression could be used for predicting the chemosensitivity of BTC patients. FUND: This work was supported by the National Science Foundation of China, Foundation of Shanghai Shen Kang Hospital Development Center, and Shanghai Outstanding Academic Leaders Plan.
氧化应激及其效应物在癌症发生和化疗耐药中起着关键作用。然而,氧化应激相关基因变异在胆道癌(BTC)化疗耐药中的作用尚不清楚。在这项工作中,我们旨在研究化学耐药性相关的氧化应激依赖性分子机制,并找到潜在的生物标志物来预测 BTC 的化疗反应。
对 367 名 BTC 患者的 21 个氧化应激相关基因中的 66 个 SNP 进行了基因分型和分析。进行免疫印迹、免疫组织化学、免疫荧光、定量 PCR、染色质免疫沉淀分析和动物异种移植模型研究,以发现与 BTC 化疗耐药机制相关的氧化应激相关易感性基因。
我们发现,3 个功能多态性(CAT_rs769217、GPX4_rs4807542 和 GSR_rs3779647),其显示影响各自基因表达水平,修饰了化疗对总体生存(OS)的影响。然后我们证明,在 BTC 细胞系中,通过升高 ROS 水平和激活 Nrf2-ABCG2 途径,敲低 GPX4、CAT 或 GSR 诱导了化疗耐药。此外,Nrf2 表达与 BTC 预后之间的关联仅在接受化疗的患者中发现。敲低 Nrf2 增强了 BTC 异种移植小鼠模型的化疗敏感性,甚至消除了术后复发。重要的是,在化疗治疗后,具有高氧化应激相关评分的患者从辅助化疗中获得了更高的生存获益,而具有低氧化应激相关评分的患者则没有。
我们的研究结果首次表明,通过结合 CAT、GPX4 和 GSR 或 Nrf2 表达的变异计算出的氧化应激相关评分可用于预测 BTC 患者的化疗敏感性。
本工作得到了中国国家自然科学基金、上海市申康医院发展中心基金会和上海市优秀学术带头人计划的支持。